Xin Cao

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of experimental & clinical cancer research : CR

Advanced biology

Cell biology and toxicology

Shanghai Institute of Organic Chemistry

China Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Institute of Organic Chemistry Feb 08 2009

China

Associate Professor :: State Key Laboratory of Bio-organic and Natural Products Chemistry

Education History

China Pharmaceutical University Sep 01 2003 - Jun 30 2008

China

PHD :: Medicianl Chemisitry

Publications

Keshu Hu, Yu Dong, Jiayu Zhang, Mengling Liu, Xun Sun, Xin Cao, Pengfei Zhang, Tianshu Liu
Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Keshu Hu, Yu Dong, Jiayu Zhang, Mengling Liu, Xun Sun, Xin Cao, Pengfei Zhang, Tianshu Liu
Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Keshu Hu, Yu Dong, Jiayu Zhang, Mengling Liu, Xun Sun, Xin Cao, Pengfei Zhang, Tianshu Liu
Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yiqing Hu, Lulan Chen, Shuang Zhao, Runyang Feng, Xin Cao, Geng Chen, Tao Zhao, Chi Zhang, Zheyan Fang, Zhenyang Guo, Xueting Yu, Zhentao Zhang, Mukaddas Abdurahman, Hangnan Hong, Yue He, Hua Li
Transcriptomics, proteomics, metabolomics and network pharmacology reveal molecular mechanisms of multi-targets effects of Shenxianshengmai improving human iPSC-CMs beating. Clinical and translational medicine 13 (6) (2023)
Yuemei Yan, Dianyu Cao, Jian Liang, Qiaorong Yang, Di Gao, Chen Shen, Feifei Hu, Zheng Li, Yumei Han, Xin Cao, Qiang Wang
Dangui Huoxue Preparation (DHP) Ameliorates Skin Fibrosis, Inflammation, and Vasculopathy in the Bleomycin-Induced Murine Model of Systemic Sclerosis. Advanced biology (2023)
Sha Liu, Yuke Ji, Huan Li, Ling Ren, Junya Zhu, Tianjing Yang, Xiumiao Li, Jin Yao, Xin Cao, Biao Yan
EYE-503: A Novel Retinoic Acid Drug for Treating Retinal Neurodegeneration. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Ying Liang, Quanlin An, Huaxin Song, Yigang Tang, Shujun Xiao, Jiale Wu, Ni Yan, Biao Yu, Xin Cao, Min Lu
AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity. Journal of medicinal chemistry (2023)
Jinzhi Xu, Lina Zhou, Xiaojing Du, Zhuoran Qi, Sinuo Chen, Jian Zhang, Xin Cao, Jinglin Xia
Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells. Metabolites 13 (11) (2023)
Heng Jiao, Xin Cao
Key characters of glycodrugs. Medicinal research reviews (2023)
Xiao-Jing Du, Zhuoran Qi, Jinzhi Xu, Mengzhou Guo, Xingxing Zhang, Zhijie Yu, Xin Cao, Jing-Lin Xia
Loss of GABARAPL1 confers ferroptosis resistance to cancer stem-like cells in hepatocellular carcinoma. Molecular oncology 16 (20) (2022)
Linfeng Zheng, Xiangyang Qin, Jiao Wang, Mengying Zhang, Quanlin An, Jinzhi Xu, Xiaosheng Qu, Xin Cao, Bing Niu
Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches. Biomolecules 12 (10) (2022)
Feng Qi, Wenxing Qin, Yao Zhang, Yongde Luo, Bing Niu, Quanlin An, Biwei Yang, Keqing Shi, Zhijie Yu, Junwei Chen, Xin Cao, Jing-Lin Xia
Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Zhusong Cao, Jianye Li, Youwen Sun, Hanwen Zhang, Xueling Mo, Xin Cao, Guozhu Zhang
Photo-induced copper-catalyzed alkynylation and amination of remote unactivated C(sp3)-H bonds. Chemical science 12 (13) (2021)
Chenyang Wu, Xin Cao, Xiaojin Zhang
VISTA inhibitors in cancer immunotherapy: a short perspective on recent progresses. RSC medicinal chemistry 12 (10) (2021)
Jiayun Hou, Xin Cao, Yunfeng Cheng, Xiangdong Wang
Roles of TP53 gene in the development of resistance to PI3K inhibitor resistances in CRISPR-Cas9-edited lung adenocarcinoma cells. Cell biology and toxicology 36 (5) (2020)
Qian Song, Quanlin An, Bing Niu, Xiaoling Lu, Ning Zhang, Xin Cao
Role of miR-221/222 in Tumor Development and the Underlying Mechanism. Journal of oncology 2019 (2019)
Ruirui Liang, Yi Lu, Xiaosheng Qu, Linfeng Zheng, Chunxia Li, Sijing Xia, Yongxin Liu, Qiang Zhang, Xin Cao, Qin Chen, Bing Niu
Prediction for global African swine fever outbreaks based on a combination of random forest algorithms and meteorological data. Transboundary and emerging diseases 67 (2) (2019)
Junwei Chen, Xin Cao, Quanlin An, Yao Zhang, Ke Li, Wenting Yao, Fuchun Shi, Yanfang Pan, Qiong Jia, Wenwen Zhou, Fang Yang, Fuxiang Wei, Ning Wang, Biao Yu
Inhibition of cancer stem cell like cells by a synthetic retinoid. Nature communications 9 (1) (2018)
Renzeng Shen, Stephane Laval, Xin Cao, Biao Yu
Synthesis of Δ20-Ginsenosides Rh4, (20E)-Rh3, Rg6, and Rk1: A General Approach To Access Dehydrated Ginsenosides. The Journal of organic chemistry 83 (5) (2018)

Xin Cao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xin Cao